Skip to Content
American Heart Association
Sign-in / Sign-up
Join or Renew
My Local Events
Find out what is happening at your local American Heart
Have an account?
Need an account?
Login with Your Social Identity:
Statements & Guidelines
FDA approves evolocumab, a PCSK9 inhibitor, to treat certain patients with high cholesterol
Noninvasive Risk Stratification
AHA/ACCF/HRS Noninvasive Risk Stratification Techniques for Identifying Patients At Risk for Sudden Cardiac Death
SCD results in significant morbidity in the U.S.
Most sufferers have an underlying cardiac pathophysiological condition
Risk stratification is essential to identify at risk individuals.
Read full article in
Editorial: Risk Stratification for Sudden Death in 2008: Where Are We Now? Where Should We Go?
Top Ten Things to Know
Professional Online Network
JOIN OUR NETWORK
Already in the network?